AMANDA SUMMERFIELD: Open Payments
NPI 1144591355 · PHILIPPI, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 34 payments from 9 companies in 2025. Trend: 2023 $1,424 · 2024 $785 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $308 |
| Exact Sciences Corporation | 4 | $111 |
| Sumitomo Pharma America, Inc. | 5 | $111 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| PFIZER INC. | 1 | $15 |
Products named: UBRELVY, Cologuard Collection Kit, GEMTESA, QULIPTA, VRAYLAR, CAPVAXIVE, LINZESS, Wegovy.
Industry payments across WV — which companies pay providers there.
